Catalyst
Slingshot members are tracking this event:
Tal Medical (PTCHF) Announces Results from Proof-of-Concept Study RAPID Evaluating Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| Tal Medical |
|
|
PTCHF |
|
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 01, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Proof-of-concept Study, Low Field Magnetic Stimulation Augmentation, Antidepressant Therapy, Treatment-resistant Depression, Rapid
